Structural and biophysical characterisation of ubiquitin variants that inhibit the ubiquitin conjugating enzyme Ube2d2
The FEBS Journal · 2024
DOI: 10.1111/febs.17311 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2024. Verfasst von Jeffery M R B McAlpine und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Ubiquitin-Conjugating Enzymes, Ubiquitin, Protein Binding. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Health Research Council of New Zealand.
Abstract (Originalsprache)
The ubiquitin‐conjugating E2 enzymes play a central role in ubiquitin transfer. Disruptions to the ubiquitin system are implicated in multiple diseases, and as a result, molecules that modulate the activity of the ubiquitin system are of interest. E2 enzyme function relies on interactions with partner proteins, and the disruption of these is an effective way to modulate activity. Here, we report the discovery of ubiquitin variants (UbVs) that inhibit the E2 enzyme, Ube2d2 (UbcH5b). The six UbVs identified inhibit ubiquitin chain building, and the structural and biophysical characterisation of two of these demonstrate they bind to Ube2d2 with low micromolar affinity and high specificity. Both characterised UbVs bind at a site that overlaps with E1 binding, while the more inhibitory UbV has an additional binding site that blocks a critical non‐covalent ubiquitin‐binding site on the E2 enzyme. The discovery of novel protein‐based ubiquitin derivatives that inhibit protein–protein interactions is an important step towards discovering small molecules that inhibit the activity of E2 enzymes. Furthermore, the specificity of the UbVs within the Ube2d family suggests that it may be possible to develop tools to selectively inhibit highly related E2 enzymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
- Department of Pharmacy, University of Waterloo, Kitchener, Canada.
- Biomolecular Interaction Centre, Maurice Wilkins Centre for Biodiscovery, MacDiarmid Institute for Advanced Materials and Nanotechnology, and School of Biological Sciences, University of Canterbury, Christchurch, New Ze…
- Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.
ORCID-Profile: Catherine L Day, Adam J Middleton
Förderung
- Health Research Council of New Zealand
Zitieren
APA
McAlpine, J. M. R. B., Zhu, J., Pudjihartono, N., Teyra, J., Currie, M. J., Tillett, Z. D., Dobson, R. C. J., Sidhu, S. S., Day, C. L., & Middleton, A. J. (2024). Structural and biophysical characterisation of ubiquitin variants that inhibit the ubiquitin conjugating enzyme Ube2d2. The FEBS Journal. https://doi.org/10.1111/febs.17311
Vancouver
McAlpine JMRB, Zhu J, Pudjihartono N, Teyra J, Currie MJ, Tillett ZD, et al. Structural and biophysical characterisation of ubiquitin variants that inhibit the ubiquitin conjugating enzyme Ube2d2. The FEBS Journal. 2024. doi:10.1111/febs.17311
BibTeX
@article{McAlpine2024,
author = {McAlpine, Jeffery M R B and Zhu, Jingyi and Pudjihartono, Nicholas and Teyra, Joan and Currie, Michael J and Tillett, Zachary D and Dobson, Renwick C J and Sidhu, Sachdev S and Day, Catherine L and Middleton, Adam J},
title = {Structural and biophysical characterisation of ubiquitin variants that inhibit the ubiquitin conjugating enzyme Ube2d2},
journal = {The FEBS Journal},
year = {2024},
doi = {10.1111/febs.17311}
}
EUVIMED